{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Crab Trap Winner Spotlight: Perfusion Medical's Mission Against Hemorrhagic Shock","description":"In this episode of BioTalk, CEO Gerard Eldering explains how Perfusion Medical is addressing a problem that trauma physicians and military medics have been struggling with for decades: capillary compression.  Perfusion Medical is developing a drug aimed at treating hemorrhagic shock and other ischemic conditions. PM\u2011208 is a novel IV therapeutic designed to restore capillary blood flow, resolve ischemia, and protect vital organs. The team has advanced this work with $19 million in Department of Defense funding. He describes the scale of the unmet need, why PM\u2011208 is both organ- and disease\u2011agnostic, and how its simple formulation and strong safety profile position it for broad medical use. Eldering also reflects on the company\u2019s path through the BioHealth Capital Region Crab Trap Competition. After a second\u2011place finish a few years earlier, Perfusion Medical returned to the stage and won the 2025 competition. He shares what that experience has meant for the team and why building the company in the BioHealth Capital Region\u2014particularly from a Virginia base\u2014has been a strategic advantage. The conversation moves through the role of early federal funding and programs like SBIR\/STTR in de\u2011risking breakthrough therapies, and how university research partnerships have strengthened PM\u2011208\u2019s development. Eldering highlights how public\u2011private collaboration has shaped the company's progress and made it possible to push a complex medical solution toward patients more quickly.   Editing and post-production work for this episode was provided by The Podcast Consultant - https:\/\/thepodcastconsultant.com\/0   About Gerard Eldering Gerard Eldering is the CEO of Perfusion Medical and a nationally recognized expert in technology transfer and venture formation. Since becoming an entrepreneur in 2007, he has helped launch more than a dozen startups, raised more than $15 million in seed funding, and led the turnaround and sale of a technology consulting firm. Before founding Perfusion Medical, he built and led The MITRE Corporation\u2019s Technology Transfer Office. Eldering is a U.S. Air Force veteran who served as a helicopter pilot and instructor. He holds a B.A. in Physics, an M.B.A., and is a registered patent agent. ","author_name":"BioTalk with Rich Bendis","author_url":"http:\/\/www.biohealthinnovation.org\/","html":"